SECURITIES PURCHASE
AGREEMENT
This Securities
Purchase Agreement (this “ Agreement ”)
is made and entered into as of August 9, 2005 (the “
Execution Date ”), by and among Zix
Corporation, a Texas corporation (the “ Company
”), and each of the purchasers listed on
Schedule A attached hereto (collectively, the “
Purchasers ” and individually, a “
Purchaser ”).
WHEREAS, the
Company desires to sell to the Purchasers, and the Purchasers
desire to purchase from the Company, up to an aggregate of
10,503,862 units (each a “ Unit ”), each
Unit consisting of one share of common stock, par value $.01 per
share, of the Company (“ Common Stock ”)
and a five year warrant (a “ Warrant ”)
to purchase one-third of one share of Common Stock, on the terms
and conditions set forth in this Agreement; and
WHEREAS, the
Company and each Purchaser are executing and delivering this
Agreement in reliance upon an exemption from securities
registration afforded by Regulation D (“
Regulation D ”) as promulgated by the
Securities and Exchange Commission (the “ SEC
”) under the Securities Act of 1933, as amended (the “
Securities Act ”).
NOW, THEREFORE, in
consideration of the foregoing, the mutual promises hereinafter set
forth, and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:
1.
AGREEMENT TO PURCHASE AND SELL STOCK .
(a)
Company Authorization . The Company’s Board of
Directors has authorized the issuance and sale, pursuant to the
terms and conditions of this Agreement, of up to 10,503,862 shares
of Common Stock (the “ Purchased Shares
”) and up to 3,466,274 Warrants, substantially in the form
attached hereto as Exhibit A . Each Warrant shall be
exercisable to purchase the number of shares of Common Stock set
forth thereon at a price of $3.04 per share of Common Stock (the
“ Purchased Warrants ” and together with
the Purchased Shares, the “ Purchased
Securities ”). Subject to their terms and conditions,
the Purchased Warrants shall be exercisable at any time and from
time to time from and after the six-month anniversary of the
Closing Date through and including August 9, 2010.
(b)
Agreement to Purchase and Sell Securities .
(i) Subject
to the terms and conditions of this Agreement, each Purchaser,
severally and not jointly, agrees to purchase, and the Company
agrees to sell to each Purchaser, at the Closing (as defined
below), that number of Units (including the Firm Units and Excess
Units, each as defined below) set forth opposite such
Purchaser’s name on Schedule A attached hereto.
The purchase price of each Unit shall be $2.50 (the “
Per Unit Price ”), except in the case of each
Unit purchased by a director or officer of the Company which shall
be $2.99 (the “ Insider Per Unit Price ”)
and each shall be payable as hereafter set forth.
(ii) Notwithstanding
anything to the contrary in this Agreement, on the Closing Date, no
more than 6,302,318 Units representing 6,302,318 shares of Common
Stock (the “ Firm Shares ”) and
associated Warrants (the “Firm Warrants”
, and together with the Firm Shares, the “Firm
Units” ) shall be issued to the Purchasers prior to
the Company obtaining shareholder approval to issue to the
Purchasers the shares of Common Stock in excess of the Firm Units
in accordance with the requirements of NASDAQ Rule 4350(i) and
Section 5(d) hereto (the “ Shareholder Approval
”). Prior to obtaining the Shareholder Approval, the Units to
be purchased by the Purchasers (including the Warrants thereto)
representing Purchased Shares in excess of the Firm Units (the
“ Excess Units ”) shall not be issued to
the Purchasers and instead the proceeds in respect of such Excess
Units (the “ Excess Funds ”) shall be
deposited into escrow, in accordance with the terms of an escrow
agreement, substantially in the form of Exhibit D
hereto (the “ Escrow Agreement ”). The
Excess Funds shall accrue interest from and including the day
following the Closing Date to and excluding the date of release in
accordance with the terms of the Escrow Agreement at a rate of 7.0%
per annum (computed on the basis of a 365-day year). If the Company
obtains the Shareholder Approval prior to the Shareholder Approval
Date (as defined below), the Excess Funds shall be released to the
Company in accordance with the Escrow Agreement, and the Excess
Units shall be issued to each of the Purchasers in the amounts set
forth on Schedule A hereto, along with such
Purchaser’s pro rata share of accrued interest on the Excess
Funds to such date, which shall be payable in cash. If the Company
does not obtain the Shareholder Approval prior to the Shareholder
Approval Date (as defined below), the Excess Funds shall be
returned to each of the Purchasers in accordance with the terms of
the Escrow Agreement, along with such Purchaser’s pro rata
share of accrued interest on the Excess Funds to such date. If the
Excess Funds accrue earnings or interest in escrow at a rate less
than the rate required by this Section 1(b)(ii) , the
Company shall promptly pay to the Purchasers any shortfall
amount.
(c)
Use of Proceeds . The Company intends to use the net
proceeds from the sale of the Purchased Securities for working
capital and general corporate purposes as determined by the Company
from time to time.
(d)
Obligations Several, Not Joint . The obligations of each
Purchaser under this Agreement are several and not joint with
respect to the obligations of any other Purchaser, and no Purchaser
shall be responsible in any way for the performance of the
obligations of any other Purchaser under this Agreement. The
decision of each of the Purchasers to purchase the Purchased
Securities pursuant to this Agreement has been made by such
Purchaser independently of any other Purchaser. Nothing contained
herein, and no action taken by any Purchaser pursuant hereto, shall
be deemed to constitute the Purchasers as a partnership, an
association, a joint venture or any other kind of entity, or create
a presumption that the Purchasers are in any way acting in concert
or as a group with respect to such obligations or the transactions
contemplated by this Agreement. Each Purchaser shall be entitled to
independently protect and enforce such Purchaser’s rights,
including, without limitation, the rights arising out of this
Agreement, and it shall not be necessary for any other Purchaser to
be joined as an additional party in any proceeding for such
purpose.
2.
CLOSING . The purchase and sale of the Purchased
Securities shall take place at the offices of Baker Botts L.L.P.,
2001 Ross Avenue, Dallas, Texas 75201, at 2:00 p.m. Dallas, Texas
time, on August 9, 2005, or at such other time and place as
the Company and Purchasers
-2-
representing a
majority of the Purchased Securities to be purchased, mutually
agree upon (which time and place are referred to in this Agreement
as the “ Closing ”). At the Closing,
against delivery of full payment for the Purchased Securities sold
hereunder by wire transfer of immediately available funds in
accordance with the Company’s instructions; the Company shall
issue and deliver to each Purchaser (i) one or more stock
certificates registered in the name of each Purchaser (or in such
nominee name(s) as designated by such Purchaser in the Stock
Certificate and Warrant Questionnaire, attached hereto as
Appendix I (the “ Stock Certificate
Questionnaire ”), representing the number of Firm
Shares set forth opposite the appropriate Purchaser’s name on
Schedule A hereto, and bearing the legend set forth in
Section 4(k)(i) herein and (ii) the number of Firm
Warrants set forth opposite the appropriate Purchaser’s name
on Schedule A hereto, and bearing the legend set forth
in Section 4(k)(ii) ; provided, however , that the
Company may furnish to each Purchaser a facsimile copy of the
warrant representing the Firm Warrant and of the stock
certificate(s) representing the Firm Shares purchased by such
Purchaser no later than the next Business Day following the Closing
Date, with the original warrant and original stock certificate(s)
to be delivered to such Purchaser by overnight courier no later
than the third (3rd) Business Day following the Closing Date.
Closing documents, other than the warrants representing the Firm
Warrants and the stock certificates representing the Firm Shares,
may be delivered by facsimile on the Closing Date, with original
signature pages subsequently sent by overnight courier.
For purposes of
this Agreement, “ Closing Date ” means
the date of the Closing, and “ Business Day
” means any day except Saturday, Sunday and any day which
shall be a federal legal holiday or a day on which banking
institutions in the State of New York are authorized or required by
law or other governmental action to close.
3.
REPRESENTATIONS, WARRANTIES AND CERTAIN AGREEMENTS OF THE
COMPANY . The Company hereby represents and warrants to
each Purchaser that, except as set forth in the SEC Documents (as
defined below) and in the Disclosure Letter attached hereto as
Exhibit B (the “ Disclosure Letter
”):
(a)
Organization Good Standing and Qualification . The Company
is a corporation duly organized, validly existing and in good
standing under the laws of the State of Texas and has all corporate
power and authority required to (i) own, operate and occupy
its properties and to carry on its business as presently conducted
and (ii) enter into this Agreement and the other agreements,
instruments and documents contemplated hereby, and to consummate
the transactions contemplated hereby and thereby. The Company is
qualified to do business and is in good standing in each
jurisdiction in which the failure to so qualify would have a
Material Adverse Effect. As used in this Agreement, “
Material Adverse Effect ” means a material
adverse effect on, or a material adverse change in, the business,
operations, financial condition, results of operations, assets or
liabilities of the Company and the Subsidiaries (as defined below),
taken as a whole.
(b)
Capitalization . The capitalization of the Company is as
follows:
(i) The
authorized capital stock of the Company consists of 175,000,000
shares of Common Stock, $.01 par value per share, and 10,000,000
shares of preferred stock, par value $1.00 per share (“
Preferred Stock ”).
-3-
(ii) As
of June 30, 2005, the issued and outstanding capital stock of
the Company consisted of 32,424,929 shares of Common Stock and no
shares of Preferred Stock. The shares of issued and outstanding
capital stock of the Company have been duly authorized and validly
issued, are fully paid and nonassessable and have not been issued
in violation of or are not otherwise subject to any preemptive or
other similar rights.
(iii) As
of June 30, 2005, the Company had 10,110,617 shares of Common
Stock reserved for issuance upon exercise of options granted under
the Company’s stock option plans.
(iv) As
of June 30, 2005, the Company had outstanding options for
8,211,325 shares of Common Stock.
(v) As
of June 30, 2005, the Company had 3,755,370 issued and
outstanding warrants for the purchase of shares of Common
Stock.
With
the exception of the foregoing in this Section 3(b) ,
there are no outstanding subscriptions, options, warrants,
convertible or exchangeable securities or other rights to purchase
shares of Common Stock or other securities of the Company, or
rights that would trigger any anti-dilution or similar adjustments
to any securities of the Company, granted to or by the Company, and
there are no commitments, plans or arrangements to issue any shares
of Common Stock or any security convertible into or exchangeable
for Common Stock.
(c)
Subsidiaries . Except for the Company’s subsidiaries
listed in the SEC documents (the “ Subsidiaries
”), the Company does not own any capital stock of, assets
comprising the business of, obligations of, or any other interest
(including any equity or partnership interest) in, any person or
entity. The Company owns, directly or indirectly, all of the issued
and outstanding shares of stock in each of the Subsidiaries. Each
of the Subsidiaries is duly organized and validly existing in good
standing under the laws of its respective state of incorporation.
Each of the Subsidiaries has full power and authority to own,
operate and occupy its properties and to conduct its business as
presently conducted and is registered or qualified to do business
and in good standing in each jurisdiction in which it owns or
leases property or transacts business and where the failure to be
so qualified would have a Material Adverse Effect.
(d)
Due Authorization . All corporate actions on the part of the
Company necessary for the authorization, execution, delivery and
performance of all obligations of the Company under this Agreement,
including the authorization, issuance, reservation for issuance and
delivery of all the Purchased Securities being sold under this
Agreement and the Common Stock issuable upon exercise of the
Purchased Warrants (the “ Warrant Shares
”), have been taken and no further consent or authorization
of the Company, the Company’s board of directors (the “
Board of Directors ”) or the Company’s
stockholders is required (other than the Shareholder Approval), and
this Agreement constitutes the legal, valid and binding obligation
of the Company, enforceable against the Company in accordance with
its terms, except (i) as may be limited by (1) applicable
bankruptcy, insolvency, reorganization or other laws of general
application relating to or affecting the enforcement of
creditors’ rights generally and (2) the effect of rules
of law governing the availability of equitable remedies and
(ii) as rights to indemnity or contribution may be limited
under federal or state securities laws or by principles of public
policy thereunder.
-4-
(e)
Valid Issuance of the Purchased Securities .
(i)
Purchased Shares . The Purchased Shares have been duly
authorized and, when issued and delivered to each Purchaser against
payment therefor in accordance with the terms of this Agreement,
will be validly issued, fully paid and non-assessable and will be
free and clear from all liens, claims and encumbrances with respect
to the issuance of such Purchased Shares and will not be subject to
any pre-emptive rights or similar rights.
(ii)
Purchased Warrants . The Purchased Warrants to be issued
pursuant to this Agreement have been duly authorized and, when
issued and delivered to each Purchaser against payment therefor in
accordance with the terms of this Agreement, will be validly issued
and will be free and clear from all liens, claims and encumbrances
with respect to the issuance of such Purchased Warrants and will
not be subject to any pre-emptive rights or similar
rights.
(iii)
Warrant Shares . The issuance of the Warrant Shares issued
or issuable from time to time upon the exercise of the Purchased
Warrants have been, and at all times prior to such exercise, will
be, duly authorized and duly reserved for issuance upon such
exercise and payment of the exercise price of the Purchased
Warrants and, when issued and delivered to each Purchaser upon
exercise against payment therefor in accordance with the terms of
the Warrant, will be validly issued, fully paid and non-assessable
and will be free and clear from all liens, claims and encumbrances
with respect to the issuance of such Warrant Shares and will not be
subject to any pre-emptive rights or similar rights.
(f)
Compliance with Securities Laws . Subject to the accuracy of
the representations made by the Purchasers in Section 4
hereof, the Purchased Securities will be issued and sold to the
Purchasers in compliance with (i) the exemption in
Rule 506 of Regulation D promulgated under the Securities
Act from the registration and prospectus delivery requirements of
the Securities Act and (ii) applicable exemptions from the
registration and qualification requirements of all applicable
securities laws of the states of the United States.
(g)
Governmental Consents . No consent, approval, order or
authorization of, or registration, qualification, designation,
declaration or filing with, or notice to, any federal, state or
local governmental authority or self regulatory agency on the part
of the Company is required in connection with the issuance and sale
of the Purchased Securities to the Purchasers by the Company or the
consummation of the other transactions contemplated by this
Agreement, except (i) such filings as have been made prior to
the date hereof, (ii) the filings under applicable securities
laws required to comply with the Company’s registration
obligations under Section 5(a) of this Agreement and
(iii) such additional post-Closing filings as may be required
to comply with applicable state and federal securities laws,
including, but not limited to, the filing of a Form D relating
to the sale of the Purchased Securities pursuant to
Regulation D.
-5-
(h)
Non-Contravention . Assuming the accuracy of the
representations and warranties made by the Purchasers in
Section 4 hereof, the execution, delivery and
performance of this Agreement by the Company, and the consummation
by the Company of the transactions contemplated hereby (including
the issuance of the Purchased Securities and the Warrant Shares),
do not: (i) contravene or conflict with the articles of
incorporation, as amended (the “ Articles of
Incorporation ”), or bylaws, as amended (the “
Bylaws ”), of the Company or of any Subsidiary;
(ii) constitute a violation of any provision of any federal, state,
local or foreign law, rule, regulation, order or decree applicable
to the Company or any Subsidiary; or (iii) constitute a
default (with or without the passage of time or giving of notice or
both) or require any consent under, give rise to any right of
termination, cancellation or acceleration of, or result in the
creation or imposition of any lien, claim or encumbrance on any
asset of the Company or the Subsidiaries under, any material
contract to which the Company or the Subsidiaries is a party or any
permit, license or similar right relating to the Company or the
Subsidiaries or by which the Company or the Subsidiaries may be
bound or affected, except in the case of clauses (ii) and
(iii), for such violations, breaches or defaults as would not be
reasonably likely to have a Material Adverse Effect.
(i)
Litigation . Except as set forth in the SEC Documents, there
is no action, suit, proceeding, claim, arbitration or investigation
(“ Action ”) pending or, to the
Company’s knowledge, threatened: (i) against the Company
or any Subsidiary, their properties or assets, or any officer,
director or employee of the Company or any Subsidiary in connection
with such officer’s, director’s or employee’s
relationship with, or actions taken on behalf of, the Company or
any Subsidiary, that would be reasonably likely to have a Material
Adverse Effect, or (ii) that seeks to prevent, enjoin, alter,
challenge or delay the transactions contemplated by this Agreement.
The Company is not a party to, nor subject to the provisions of,
any order, writ, injunction, judgment or decree of any court or
government agency or instrumentality that would reasonably be
expected to prevent, enjoin, alter, challenge or delay the
consummation of the transactions contemplated by this Agreement or
would be reasonably likely to have a Material Adverse Effect. The
SEC has not issued any stop order or other order suspending the
effectiveness of any registration statement filed by the Company
under the Securities Act or the Securities Exchange Act of 1934, as
amended ( the “ Exchange Act
”).
(j)
Compliance with Law and Charter Documents . The Company is
not in violation or default of any provisions of the Articles of
Incorporation or the Bylaws. The Company is currently in compliance
with all applicable statutes, laws, rules, regulations and orders
of the United States of America and all states thereof, foreign
countries and other governmental bodies and agencies having
jurisdiction over the Company’s business or properties,
except for any instance of non-compliance that has not had, and
would not reasonably be expected to have, a Material Adverse
Effect. Neither the Company nor any Subsidiary is in default (and
there exists no condition which, with or without the passage of
time or giving of notice or both, would constitute a default) in
any material respect in the performance of any bond, debenture,
note or any other evidence of indebtedness in any indenture,
mortgage, deed of trust or any other material agreement or
instrument to which the Company or any Subsidiary is a party or by
which the Company or any Subsidiary is bound or by which the
properties of the Company or any Subsidiary is bound, which default
would be reasonably likely to have a Material Adverse Effect or
which would be reasonably likely to have a Material Adverse Effect
on the transactions contemplated by this Agreement.
-6-
(k)
Material Non-Public Information . The Company has not
provided, and will not provide, to the Purchasers any material
non-public information other than information related to the
transactions contemplated by this Agreement, all of which
information shall be disclosed by the Company pursuant to
Section 9(m) hereof.
(1)
Reports . The Company has filed in a timely manner all
reports, schedules, forms, statements and other documents required
to be filed by it with the Securities and Exchange Commission (the
“ SEC ”) pursuant to the reporting
requirements of the Exchange Act and the rules and regulations
promulgated thereunder. The Company has made available to the
Purchasers prior to the date hereof copies of its Annual Report on
Form 10-K for the fiscal year ended December 31, 2004, as
amended (the “ Form 10-K ”), its
quarterly report on Form 10-Q for the fiscal quarter ended March
31, 2005 (the “ Form 10-Q ”), and
any Current Report on Form 8-K for events occurring since December
31, 2004 (“ Form 8-Ks ”) filed or
furnished by the Company with the SEC (the Form 10-K, the Form 10-Q
and the Form 8-Ks are collectively referred to herein as the
“ SEC Documents ”). Each of the SEC
Documents, as of the respective dates thereof (or, if amended or
superseded by a filing or submission, as the case may be, prior to
the Closing Date, then on the date of such filing or submission, as
the case may be), (1) did not contain any untrue statement of
a material fact nor omit to state a material fact necessary in
order to make the statements made therein, in light of the
circumstances under which they were made, not misleading and
(2) complied in all material respects with the requirements of
the Exchange Act and the rules and regulations of the SEC
promulgated thereunder applicable to such SEC Document.
(2)
Sarbanes-Oxley . The Chief Executive Officer and the Chief
Financial Officer of the Company have signed, and the Company has
furnished to the SEC, all certifications required by
Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. Such
certifications contain no qualifications or exceptions to the
matters certified therein (other than such qualifications or
exceptions that are permitted under the Exchange Act and the rules
promulgated thereunder) and have not been modified or withdrawn;
and neither the Company nor any of its officers has received notice
from any governmental entity questioning or challenging the
accuracy, completeness, form or manner of filing or submission of
such certifications. Without limiting the foregoing, the Company is
in compliance with any applicable requirements of the
Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated thereunder, as amended, that are currently in
effect.
(3)
Financial Statements . The consolidated financial statements
of the Company included in the SEC Documents (1) comply as to
form in all material respects with the rules and regulations of the
SEC with respect thereto as were in effect at the time of filing
and (2) present fairly, in all material respects, in
accordance with United States generally accepted accounting
principles (“ GAAP ”), consistently
applied, the consolidated financial position of the Company as of
the dates indicated therein, and the consolidated results of its
operations and cash flows for the periods therein specified,
subject, in the case of unaudited consolidated financial statements
for interim periods, to normal, immaterial year-end audit
adjustments.
-7-
(m)
Absence of Certain Changes Since the Balance Sheet Date .
Except as disclosed in the SEC Documents, since the filing of the
Company’s most recent Form 10-K with the SEC, the business
and operations of the Company and the Subsidiaries have been
conducted in the ordinary course consistent with past practice, and
there has not been:
(i) any
declaration, setting aside or payment of any dividend or other
distribution of the assets of the Company with respect to any
shares of capital stock of the Company or any repurchase,
redemption or other acquisition by the Company or any Subsidiary of
the Company of any outstanding shares of the Company’s
capital stock;
(ii) any
damage, destruction or loss to the Company’s or any
Subsidiary’s business or assets, whether or not covered by
insurance, except for such occurrences, individually and
collectively, that have not had, and would not reasonably be
expected to have, a Material Adverse Effect;
(iii) any
waiver by the Company or any Subsidiary of a valuable right or of a
material debt owed to it, except for such waivers, individually and
collectively, that have not had, and would not reasonably be
expected to have, a Material Adverse Effect;
(iv) any
material change or amendment to, or any waiver of any material
right under a material contract or arrangement by which the
Company, any Subsidiary or any of their assets or properties is
bound or subject;
(v) any
transaction between the Company or any Subsidiary, on the one hand,
and any of its officers or directors, on the other hand, that would
be required to be disclosed pursuant to Item 404(a), (b) or
(c) of Regulation S-K of the SEC;
(vi) any
change by the Company in its accounting principles, methods or
practices or in the manner in which it keeps its accounting books
and records, except any such change required by a change in GAAP or
by the SEC; or
(vii) any
other event or condition, either individually or collectively, that
has had, or would be reasonably likely to have, a Material Adverse
Effect.
(n)
Intellectual Property . The Company and its Subsidiaries own
or possess sufficient rights to use all patents, patent rights,
inventions, trade secrets, know-how, trademarks, service marks,
trade names, licenses, copyrights or other information
(collectively, “ Intellectual Property ”)
which are used to conduct their businesses as currently conducted,
except where the failure to own or possess such sufficient rights
would not reasonably be expected to result, either individually or
in the aggregate, in a Material Adverse Effect. Neither the Company
nor any Subsidiary has received any written notice of, and has no
actual knowledge of, any infringement of or conflict with asserted
rights of others with respect to any Intellectual Property which,
either individually or in the aggregate, if the subject of an
unfavorable decision, ruling or finding, would reasonably be
expected to have a Material Adverse Effect, and to the
Company’s and each of the Subsidiaries’ knowledge, none
of the patent rights owned or licensed by the Company or the
Subsidiaries are unenforceable or invalid.
-8-
(o)
Registration Rights . Except as provided in
Section 5 herein, effective upon the Closing, the
Company is not currently subject to any agreement providing any
person or entity any rights (including piggyback registration
rights) to have any securities of the Company registered with the
SEC or registered or qualified with any other governmental
authority that have not previously been satisfied.
(p)
Title to Property and Assets . The properties and assets of
the Company and the Subsidiaries are owned by the Company or the
Subsidiaries free and clear of all mortgages, deeds of trust,
liens, charges, encumbrances and security interests, except for
(i) statutory liens for the payment of current taxes that are
not yet delinquent and (ii) liens, encumbrances and security
interests that arise in the ordinary course of business and do not
in any material respect affect the business of the Company and the
Subsidiaries as currently conducted. With respect to the property
and assets it leases, each of the Company and the Subsidiaries is
in compliance with such leases in all material respects.
(q)
Taxes . The Company and the Subsidiaries have filed or have
valid extensions of the time to file all necessary federal, state,
and foreign income and franchise tax returns due prior to the date
hereof or have requested extensions thereof (except in any case in
which the failure to so file would not reasonably be expected to
have a Material Adverse Effect) and has paid or accrued all taxes
due.
(r)
Internal Accounting Controls . The Company and each of the
Subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that (i) transactions
are executed in accordance with management’s general or
specific authorizations, (ii) transactions are recorded as
necessary to permit preparation of financial statements in
conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with
management’s general or specific authorization, and
(iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences.
(s)
Market . The Company has not taken and will not take,
directly or indirectly, any action designed to, or that might
reasonably be expected to cause or result in, stabilization or
manipulation of the price of the Common Stock of the Company to
facilitate the sale or resale of the Purchased
Securities.
(t)
Investment Company . The Company is not an “investment
company” within the meaning of such term under the Investment
Company Act of 1940, as amended.
(u)
Application of Anti-Takeover Provisions . There is no
control share acquisition, business combination, poison pill or
other similar anti-takeover provision under the Company’s
Articles of Incorporation (or similar charter documents) that would
become applicable to the Purchasers as a result of the issuance of
the Company Shares and Warrant Shares.
(v)
General Solicitation . Neither the Company nor any other
Person (as defined below) authorized by the Company to act on its
behalf has engaged in a general solicitation or general advertising
(within the meaning of Regulation D) of investors with
respect
-9-
to offers or
sales of the Purchased Securities. For purposes of this Agreement,
“ Person ” means an individual or
corporation, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of
any kind.
(w)
Registration Statement Matters . The Company currently meets
the eligibility requirements for use of a Form S-3 Registration
Statement for the resale of the Registrable Shares (as defined
below) by the Purchasers. Assuming the completion and timely
delivery of the Registration Statement/Suitability Questionnaire,
attached hereto as Appendix II (the “
Registration Statement Questionnaire ”), by
each Purchaser to the Company, the Company is not aware of any
facts or circumstances that would prohibit or delay the preparation
and filing of a registration statement with respect to the
Registrable Shares.
(x)
No Integrated Offering . Neither the Company, nor any
Affiliate (as hereafter defined) of the Company, nor any person
acting on its behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any
security, under circumstances that would cause this offering of the
Purchased Securities to be integrated with prior offerings by the
Company for purposes of the Securities Act, any applicable state
securities laws or any applicable stockholder approval provisions,
nor will the Company take any action or steps that would cause the
offering of the Purchased Securities to be integrated with other
offerings.
For
purposes of this Agreement, an “ Affiliate
” of any specified Person means any other Person directly or
indirectly controlling, controlled by or under direct or indirect
common control with such specified Person. For purposes of this
definition, “ control ” means the power
to direct the management and policies of such person or firm,
directly or indirectly, whether through the ownership of voting
securities, by contract or otherwise.
(y)
Trading and Registration Matters . The Common Stock of the
Company is eligible for trading on The NASDAQ National Market under
the ticker symbol “ZIXI”. The Company has taken no
action designed to terminate, or likely to have the effect of
terminating, the listing of the Common Stock on the NASDAQ National
Market.
4.
REPRESENTATIONS, WARRANTIES AND CERTAIN AGREEMENTS OF THE
PURCHASERS . Each Purchaser, severally and not jointly,
hereby represents and warrants to the Company, and agrees
that:
(a)
Organization . Such Purchaser has all corporate, limited
liability company, partnership, trust or individual, as the case
may be, power and authority required to enter into this Agreement
and the other agreements, instruments and documents contemplated
hereby, and to consummate the transactions contemplated hereby and
thereby.
(b)
Due Authorization . All corporate, limited liability
company, partnership, trust or individual, as the case may be,
action on the part of such Purchaser necessary for the
authorization, execution, delivery of and the performance of all
obligations of such Purchaser under this Agreement have been taken
and no further consent or authorization of such Purchaser is
necessary, and this Agreement constitutes such Purchaser’s
legal, valid and binding obligation,
-10-
enforceable in
accordance with its terms, except (i) as may be limited by
(1) applicable bankruptcy, insolvency, reorganization or other
laws of general application relating to or affecting the
enforcement of creditors’ rights generally and (2) the
effect of rules of law governing the availability of equitable
remedies and (ii) as rights to indemnity or contribution may
be limited under federal or state securities laws or by principles
of public policy thereunder.
(c)
Non-Contravention . The execution, delivery and performance
of this Agreement by such Purchaser, and the consummation by such
Purchaser of the transactions contemplated hereby, do not:
(i) contravene or conflict with the organizational documents
of such Purchaser; or (ii) constitute a violation of any provision
of any federal, state, local or foreign law, rule, regulation,
order or decree applicable to such Purchaser, except in the case of
clause (ii), for such violations, breaches or defaults as would not
be reasonably likely to have a material adverse effect on such
Purchaser.
(d)
Litigation . There is no Action pending to which such
Purchaser is a party that is reasonably likely to prevent, enjoin,
alter or delay the transactions contemplated by this
Agreement.
(e)
Purchase for Own Account . The Purchased Securities are
being acquired for investment for such Purchaser’s own
account, not as a nominee or agent, in the ordinary course of
business, and not with a view to the public resale or distribution
thereof within the meaning of the Securities Act. Such Purchaser
also represents that it has not been formed for the specific
purpose of acquiring the Purchased Securities. Such Purchaser does
not have any agreement or understanding, direct or indirect, with
any other Person to sell or otherwise distribute the Purchased
Securities. Notwithstanding the foregoing, the parties hereto
acknowledge such Purchaser’s right at all times to sell or
otherwise dispose of all or any part of such securities in
compliance with applicable federal and state securities laws and as
otherwise contemplated by this Agreement.
(f)
Investment Experience . Such Purchaser understands that the
purchase of the Purchased Securities involves substantial risk.
Such Purchaser has experience as an investor in securities of
companies and acknowledges that it can bear the economic risk of
its investment in the Purchased Securities and has such knowledge
and experience in financial or business matters that it is capable
of evaluating the merits and risks of this investment in the
Purchased Securities and protecting its own interests in connection
with this investment.
(g)
Accredited Purchaser Status . Such Purchaser is an
“accredited investor” within the meaning of
Regulation D promulgated under the Securities Act.
(h)
Reliance Upon Purchaser’s Representations . Such
Purchaser understands that the sale of the Purchased Securities to
it will not be registered under the Securities Act on the ground
that such issuance and sale will be exempt from registration under
the Securities Act, and that the Company’s reliance on such
exemption is based on each Purchaser’s representations set
forth herein.
(i)
Receipt of Information . Such Purchaser has (i) had
access to the Company’s SEC Documents and (ii) has had
an opportunity to ask questions and receive answers
-11-
from the
Company regarding the terms and conditions of the sale of the
Purchased Securities and the business, properties, prospects and
financial condition of the Company and to obtain any additional
information requested and has received and considered all
information it deems relevant to make an informed decision to
purchase the Purchased Securities.
(j)
Restricted Securities and Restrictions on Transfer
.
(i) Such
Purchaser understands that the Purchased Securities and the Warrant
Shares have not been registered under the Securities Act and will
not sell, offer to sell, assign, pledge, hypothecate or otherwise
transfer any of the Purchased Securities or the Warrant Shares
(except as permitted in Section 4(k) below) unless
(A) pursuant to an effective registration statement under the
Securities Act, (B) such Purchaser provides a reasonably
acceptable legal opinion to the Company, to the effect that a sale,
assignment, pledge, hypothecation or other transfer of the
Purchased Securities or the Warrant Shares, as the case may be, may
be made without registration under the Securities Act and the
transferee agrees to be bound by the terms and conditions of this
Agreement, (C) such Purchaser provides the Company a “no
action” letter from the SEC to the effect that the transfer
of the Purchased Securities or the Warrant Shares, as the case may
be, without registration will not result in a recommendation by the
Staff of the SEC that enforcement action by taken with respect
thereto, (D) such Purchaser provides the Company with
reasonable assurances (in the form of seller and broker
representation letters) that the Purchased Securities or the
Warrant Shares, as the case may be, can be sold pursuant to
Rule 144 promulgated under the Securities Act (“
Rule 144 ”), (E) such Purchaser
provides the Company with reasonable assurances (in the form of
seller representation letters) that the Purchased Securities or the
Warrant Shares, as the case may be, can be sold pursuant to Rule
144(k) promulgated under the Securities Act following the
applicable holding period or (F) pursuant to any other
exception contained in the Securities Act provided that the
Purchaser provides a reasonably acceptable legal opinion to the
Company. Notwithstanding anything to the contrary contained in this
Agreement, including but not limited to in
Section 5(c)(i) below, such Purchaser may transfer the
Purchased Securities or the Warrant Shares to its Affiliates
provided that (X) such Purchas
|